Screening For Cervical Cancers
Published on Mar 13 2010, in the categories: diagnosis, Facts, tests, Useful info
Smears: first weapon against cancer of the cervix ; The cervical cancer remains a global health problem. But the smear screening has reduced mortality by 70% in industrialized countries. And considering that nearly 90% of deaths could be prevented by better screening.
The smear of the cervix can simultaneously reduce the number of cancer and reduce its severity. Because they detect either precancerous lesions or cancer at the initial stages it would be impossible to diagnose with other technical developments such as cancer cause no symptoms.
For an effective screening - For screening to be effective, however a condition is necessary: the regularity. You need to smear every 3 years after two normal tests conducted one year apart. At what age? It is recommended to start between 20 to 25 years to 70 years and over, until you have a sex life.
Other recommendations are important for the smear can be achieved under good conditions.This must be done away from sex (at least 48 hours after) and without menstrual periods. The occurrence of infection or limitation of local therapy also requires to postpone consideration until later. Finally, if you are menopausal, your doctor may prescribe an examination before estrogen treatment.
An easy consideration - The technique is simple: the doctor removes some cells from the cervix during your pelvic exam and spread on a slide. This allows a doctor to examine cytopathologist. Today, research has established a link between a virus, HPV or HPV and the occurrence of cervical cancer. Thus, some call for a strengthening of smear screening tests to detect these viruses.
While its use remains the subject of much debate, the test for HPV will be reimbursed by Social Security since February 14, 2004 under the following single statement: equivocal smears of undetermined significance (ASCUS). The reimbursement will be based on the rating B180, which corresponds to 48.60 euros.
The only test available on the market marketed by Digene laboratory will allow the practitioner to sort out the misunderstanding when smear cytology only allows dubious interpretation. A single reimbursement per patient is predicted even if the repetition of this examination may be justified in cases of positivity of the first positive test or in immuno-compromised patients.
If a first mark some smear abnormalities, especially do not worry. In most cases this injury completely benign or cancer in very preliminary stages. After the biopsy, the doctor will choose the appropriate treatment for you or, in the case of a mild or severe dysplasia, close monitoring, a vaporization of the lesion, excision (or removal) of part of the neck where injury or, in rare cases, a more extensive surgery or radiotherapy. But in any case, regular monitoring will be imposed later, at least during the early years.
The smear of the cervix can simultaneously reduce the number of cancer and reduce its severity. Because they detect either precancerous lesions or cancer at the initial stages it would be impossible to diagnose with other technical developments such as cancer cause no symptoms.
For an effective screening - For screening to be effective, however a condition is necessary: the regularity. You need to smear every 3 years after two normal tests conducted one year apart. At what age? It is recommended to start between 20 to 25 years to 70 years and over, until you have a sex life.
Other recommendations are important for the smear can be achieved under good conditions.This must be done away from sex (at least 48 hours after) and without menstrual periods. The occurrence of infection or limitation of local therapy also requires to postpone consideration until later. Finally, if you are menopausal, your doctor may prescribe an examination before estrogen treatment.
An easy consideration - The technique is simple: the doctor removes some cells from the cervix during your pelvic exam and spread on a slide. This allows a doctor to examine cytopathologist. Today, research has established a link between a virus, HPV or HPV and the occurrence of cervical cancer. Thus, some call for a strengthening of smear screening tests to detect these viruses.
While its use remains the subject of much debate, the test for HPV will be reimbursed by Social Security since February 14, 2004 under the following single statement: equivocal smears of undetermined significance (ASCUS). The reimbursement will be based on the rating B180, which corresponds to 48.60 euros.
The only test available on the market marketed by Digene laboratory will allow the practitioner to sort out the misunderstanding when smear cytology only allows dubious interpretation. A single reimbursement per patient is predicted even if the repetition of this examination may be justified in cases of positivity of the first positive test or in immuno-compromised patients.
If a first mark some smear abnormalities, especially do not worry. In most cases this injury completely benign or cancer in very preliminary stages. After the biopsy, the doctor will choose the appropriate treatment for you or, in the case of a mild or severe dysplasia, close monitoring, a vaporization of the lesion, excision (or removal) of part of the neck where injury or, in rare cases, a more extensive surgery or radiotherapy. But in any case, regular monitoring will be imposed later, at least during the early years.
If you liked this post, subscribe to our blog by filling your e-mail address below:
Want to add something? Post your comments